name:-0.02324390411377
name:-0.020112991333008
name:-0.00079703330993652
Signal Pharmaceuticals, Inc. Patent Filings

Signal Pharmaceuticals, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Signal Pharmaceuticals, Inc..The latest application filed is for "compounds and methods for modulating activation of nf-kb".

Company Profile
0.17.19
  • Signal Pharmaceuticals, Inc. -
  • Signal Pharmaceuticals, Inc. - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Compounds And Methods For Modulating Activation Of Nf-kb
App 20090233855 - MANNING; Anthony M. ;   et al.
2009-09-17
Stimulus Inducible Protein Kinase Complex and Methods of Use Therefor
App 20090169564 - Mercurio; Frank ;   et al.
2009-07-02
Compounds and methods for modulating activation of NF-kappaB
App 20070208167 - Manning; Anthony M. ;   et al.
2007-09-06
Mitogen-activated protein kinase p38-2 and methods of use therefor
Grant 7,202,049 - Stein , et al. April 10, 2
2007-04-10
Mitogen-activated protein kinase kinase MEK6 and methods of use thereof
App 20060110799 - Stein; Bernd ;   et al.
2006-05-25
Mitogen-activated protein kinase kinase MEK6 and methods of use therefor
App 20050255094 - Stein, Bernd ;   et al.
2005-11-17
Human mesencephalon cell lines and methods of use therefor
App 20050124007 - Sah, Dinah W. Y. ;   et al.
2005-06-09
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
Grant 6,897,231 - Bhagwat , et al. May 24, 2
2005-05-24
PNS cell lines and methods of use therefor
App 20050095701 - Sah, Dinah W. Y. ;   et al.
2005-05-05
Compounds and methods for modulation of estrogen receptors
App 20050004360 - Gayo-Fung, Leah Marie ;   et al.
2005-01-06
PNS cell lines and methods of use therefor
Grant 6,835,567 - Sah , et al. December 28, 2
2004-12-28
Mitogen-activated protein kinase kinase MEK6 and methods of use thereof
App 20040235112 - Stein, Bernd ;   et al.
2004-11-25
Compounds and methods for modulation of estrogen receptors
App 20040082575 - Bhagwat, Shripad S. ;   et al.
2004-04-29
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
App 20040077877 - Bhagwat, Shripad S. ;   et al.
2004-04-22
Compounds and methods for modulation of estrogen receptors
Grant 6,686,351 - Bhagwat , et al. February 3, 2
2004-02-03
Mitogen-activated protein kinase p38-2 and methods of use therefor
Grant 6,677,130 - Stein , et al. January 13, 2
2004-01-13
Compounds and methods for modulating activation of NF-.kappa.B
Grant 6,656,713 - Manning , et al. December 2, 2
2003-12-02
Mitogen-activated protein kinase MEK6 and methods of use therefor
App 20030175928 - Stein, Bernd ;   et al.
2003-09-18
Benzopyrazone compounds, compositions thereof, and methods of treatment therewith
Grant 6,620,838 - McKie , et al. September 16, 2
2003-09-16
Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis
App 20030149025 - Zeldis, Jerome B.
2003-08-07
Compounds and methods for modulation of estrogen receptors
Grant 6,593,322 - Bhagwat , et al. July 15, 2
2003-07-15
Methods for modulating signal transduction mediated by TGF-beta related proteins
App 20030119072 - Hoekstra, Merl F. ;   et al.
2003-06-26
Compounds and methods for modulation of estrogen receptors
App 20030087901 - Bhagwat, Shripad S. ;   et al.
2003-05-08
Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related thereto
App 20030073732 - Sakata, Steven T. ;   et al.
2003-04-17
Mitogen-activated protein kinase p38-2 and methods of use therefor
App 20030059881 - Stein, Bernd ;   et al.
2003-03-27
Mitogen-activated protein kinase p38-2 and methods of use therefor
App 20030054528 - Stein, Bernd ;   et al.
2003-03-20
Method for the affinity isolation of newly synthesized RNA
App 20020146739 - Pardinas, Jose R. ;   et al.
2002-10-10
Compounds and methods for modulation of estrogen receptors
Grant 6,436,923 - Bhagwat , et al. August 20, 2
2002-08-20
Compounds and methods for modulation of estrogen receptors
Grant 6,331,562 - Bhagwat , et al. December 18, 2
2001-12-18
Compounds and methods for modulation of estrogen receptors
Grant 6,291,456 - Stein , et al. September 18, 2
2001-09-18
Mitogen-activated protein kinase p38-2 and methods of use therefor
Grant 5,948,885 - Stein , et al. September 7, 1
1999-09-07
Reporter cell line system for detecting cytomegalovirus and identifying modulators of viral gene expression
Grant 5,945,276 - Wu , et al. August 31, 1
1999-08-31
Quinazoline analogs and related compounds and methods for treating inflammatory conditions
Grant 5,939,421 - Palanki , et al. August 17, 1
1999-08-17
Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions
Grant 5,935,966 - Suto , et al. August 10, 1
1999-08-10
Human oligodendroglial progenitor cell line
Grant 5,830,651 - Cauley , et al. November 3, 1
1998-11-03
Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
Grant 5,811,428 - Suto , et al. September 22, 1
1998-09-22
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed